{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:25:06Z","timestamp":1792207506184,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.medcli.2011.11.011","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:30:51Z","timestamp":1326760251000},"page":"261.e1-261.e17","source":"Crossref","is-referenced-by-count":18,"title":["Diagn\u00f3stico, tratamiento y seguimiento de la trombocitopenia inmune primaria"],"prefix":"10.1016","volume":"138","author":[{"given":"Miguel \u00c1ngel","family":"Sanz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Vicente Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Fernanda","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Jarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eva","family":"Mingot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Monteagudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Ma","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Valc\u00e1rcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2011.11.011_bib0005","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2004-12-4598","article-title":"How I treat idiopathic thrombocytopenic purpura (ITP)","volume":"106","author":"Cines","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0015","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0020","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0025","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review","volume":"113","author":"Stasi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0030","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","article-title":"The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts","volume":"160","author":"Cohen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medcli.2011.11.011_bib0035","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","article-title":"Morbidity and mortality in adults with idiopathic thrombocytopenic purpura","volume":"97","author":"Portielje","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0040","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1182\/blood-2005-12-015222","article-title":"Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience","volume":"109","author":"Mazzucconi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0045","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1538-7836.2009.03359.x","article-title":"Faster platelet recovery by high-dose dexamethasone compared with standard-dose prednisolone in adult immune thrombocytopenia: a prospective randomized trial","volume":"7","author":"Praituan","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2011.11.011_bib0050","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0055","first-page":"72","article-title":"Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases","volume":"90","author":"Vianelli","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2011.11.011_bib0060","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00464-007-9735-5","article-title":"Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES)","volume":"22","author":"Habermalz","year":"2008","journal-title":"Surg Endosc"},{"key":"10.1016\/j.medcli.2011.11.011_bib0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7861\/clinmedicine.2-5-440","article-title":"Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen","volume":"2","author":"Davies","year":"2002","journal-title":"Clin Med"},{"key":"10.1016\/j.medcli.2011.11.011_bib0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10096-009-0870-x","article-title":"Management of post-splenectomy patients in the Netherlands","volume":"29","author":"Lammers","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medcli.2011.11.011_bib0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0009-739X(07)71313-1","article-title":"Prevenci\u00f3n de la sepsis en pacientes esplenectomizados","volume":"81","author":"Lamsfus-Prieto","year":"2007","journal-title":"Cir Esp"},{"key":"10.1016\/j.medcli.2011.11.011_bib0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MOH.0b013e3282b9748f","article-title":"Immune thrombocytopenic purpura in adults","volume":"14","author":"Godeau","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0085","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood-2008-04-150078","article-title":"Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP","volume":"113","author":"Bussel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0090","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1002625","article-title":"Romiplostim or standard of care in patients with immune thrombocytopenia","volume":"363","author":"Kuter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2011.11.011_bib0095","unstructured":"Nplate\u00ae (romiplostim). Ficha t\u00e9cnica [consultado 28\/12\/2011]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000942\/WC500039537.pdf"},{"key":"10.1016\/j.medcli.2011.11.011_bib0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","article-title":"Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Bussel","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2011.11.011_bib0105","unstructured":"Revolade\u00ae (eltrombopag). Ficha t\u00e9cnica [consultado 28\/12\/2011]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/001110\/WC500089964.pdf"},{"key":"10.1016\/j.medcli.2011.11.011_bib0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2141.2008.07275.x","article-title":"Refractory immune thrombocytopenic purpura: current strategies for investigation and management","volume":"143","author":"Psaila","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","article-title":"Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura","volume":"146","author":"Arnold","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2011.11.011_bib0120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1157\/13100563","article-title":"Utilidad del rituximab en el tratamiento de pacientes con enfermedades sist\u00e9micas autoinmunitarias","volume":"128","author":"Garc\u00eda Hern\u00e1ndez","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2011.11.011_bib0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1157\/13115032","article-title":"Rituximab en el tratamiento de enfermedades autoinmunitarias: resultados del registro de la Asociaci\u00f3n Andaluza de Enfermedades Autoinmunes","volume":"130","author":"Callejas Rubio","year":"2008","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2011.11.011_bib0130","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3324\/haematol.12206","article-title":"Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura","volume":"93","author":"Zaja","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2011.11.011_bib0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2010.01486.x","article-title":"Low dose rituximab in adult patients with primary immune thrombocytopenia","volume":"85","author":"Zaja","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0140","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2008-01-131029","article-title":"Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study","volume":"112","author":"Godeau","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0145","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2009-07-229815","article-title":"Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia","volume":"115","author":"Zaja","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0150","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2146\/ajhp080493","article-title":"New options after first-line therapy for chronic immune thrombocytopenic purpura","volume":"66","author":"Burzynski","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.medcli.2011.11.011_bib0155","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1182\/blood-2007-01-065763","article-title":"Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)","volume":"110","author":"Boruchov","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2141.2001.03039.x","article-title":"The effect of treatment with Campath-1H in patients with autoimmune cytopenias","volume":"114","author":"Willis","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0165","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/08916930802198436","article-title":"Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias","volume":"41","author":"Passweg","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.medcli.2011.11.011_bib0170","doi-asserted-by":"crossref","first-page":"414.e1","DOI":"10.1016\/j.anpedi.2010.11.004","article-title":"Protocolo de estudio y tratamiento de la trombocitopenia inmune primaria (PTI-2010)","volume":"74","author":"Monteagudo","year":"2011","journal-title":"An Pediatr"},{"key":"10.1016\/j.medcli.2011.11.011_bib0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0268-960X(02)00056-5","article-title":"Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management","volume":"17","author":"McCrae","year":"2003","journal-title":"Blood Rev"},{"key":"10.1016\/j.medcli.2011.11.011_bib0180","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MOH.0b013e3282bf6dc2","article-title":"Immune thrombocytopenic purpura in pregnancy","volume":"14","author":"Gernsheimer","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0185","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1182\/blood-2002-10-3317","article-title":"A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura","volume":"102","author":"Webert","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.11.011_bib0190","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.hoc.2009.08.005","article-title":"Immune thrombocytopenia in pregnancy","volume":"23","author":"Stavrou","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.medcli.2011.11.011_bib0195","first-page":"CD007722","article-title":"Medical treatments for idiopathic thrombocytopenic purpura during pregnancy","author":"Marti-Carvajal","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medcli.2011.11.011_bib0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajh.21060","article-title":"Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients","volume":"83","author":"Spahr","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0609.2005.00602.x","article-title":"Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients","volume":"76","author":"Bizzoni","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejim.2007.07.006","article-title":"Idiopathic thrombocytopenic purpura in elderly patients: a study of 47 cases from a single reference center","volume":"19","author":"Daou","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.medcli.2011.11.011_bib0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/cncr.22434","article-title":"Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes","volume":"109","author":"Sarkiss","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.medcli.2011.11.011_bib0220","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/MBC.0b013e32832ff577","article-title":"Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy","volume":"20","author":"Tousovska","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.medcli.2011.11.011_bib0225","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1213\/ane.0b013e3181ac13d1","article-title":"Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses","volume":"109","author":"Choi","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.medcli.2011.11.011_bib0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jac\/dkm195","article-title":"Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"60","author":"Franchini","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medcli.2011.11.011_bib0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MOH.0b013e3282ab9904","article-title":"Secondary immune thrombocytopenic purpura","volume":"14","author":"Liebman","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0240","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2141.2005.05542.x","article-title":"Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura","volume":"129","author":"Rajan","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/157016206775197646","article-title":"Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression","volume":"4","author":"Sundell","year":"2006","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.medcli.2011.11.011_bib0250","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1365-2141.2001.03194.x","article-title":"Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura","volume":"115","author":"Jarque","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2011.11.011_bib0255","series-title":"Hematology: basic principles and practice","author":"Hoffman","year":"2009"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775311011626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775311011626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T02:21:37Z","timestamp":1543285297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775311011626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0025775311011626"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2011.11.011","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}